Dr. Sarah Cole, our VP of R&D and Operations, was invited to participate in an expert panel as part of the BIO-Europe conference.
The panel included investors, biotech and pharma representatives examining the innovative approaches taken to develop future treatments so badly needed for neurodegenerative diseases.
Neurodegeneration is a central mechanism in multiple hard-to-treat diseases and the discussion focused on opportunities presented by emerging new modalities, including gene therapy, to control it. An up-to-date status of the remaining challenges in the field such as delivery and cell specificity, and how they are being addressed, was also debated. Overall a fantastic session!